SR-7 Double Nickase Plasmid (h): sc-404174-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- SR-7 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- SR-7 Double Nickase Plasmid (h) and SR-7 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting HTR7. One or both designs may be available
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SR-7 Double Nickase Plasmid (h) | sc-404174-NIC | 20 µg | $410.00 | |||
SR-7 Double Nickase Plasmid (h2) | sc-404174-NIC-2 | 20 µg | $410.00 |
Human HTR7 encodes the serotonin receptor 7 (SR-7), a G protein–coupled receptor that primarily signals through Gαs to stimulate adenylyl cyclase, elevate cAMP, and engage PKA/CREB-dependent transcriptional programs. SR-7 also interfaces with β-arrestin scaffolding and can influence ERK/MAPK signaling, linking serotonergic inputs to changes in neuronal excitability, synaptic plasticity, and circadian regulation. In the central nervous system, HTR7 activity contributes to neurodevelopmental and neurophysiological processes, and dysregulated serotonergic GPCR signaling has been associated with neuropsychiatric and sleep-related phenotypes. Outside the brain, SR-7–mediated cAMP signaling provides a tractable pathway for studying GPCR desensitization, receptor trafficking, and second-messenger dynamics.
SR-7 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the HTR7 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within HTR7. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt HTR7 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of HTR7-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.